Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-04-16FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for desipramine hydrochloride from Heritage Pharmaceuticals (Avet) to support a marketed generic pro…
-
FDA approval · 2019-04-15FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin's original (generic) application for fluoxetine hydrochloride.
-
FDA approval · 2019-03-29FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Venlafaxine Hydrochloride from Sun Pharmaceutical Industries to support the generic product's co…
-
FDA approval · 2019-03-27FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for doxepin hydrochloride from Aurobindo Pharma Limited, granting generic approval for this product.
-
FDA approval · 2019-03-20FDA Approved: FLUOXETINE — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approved ScieGen Pharmaceuticals' original application for fluoxetine, authorizing the marketing of a generic fluoxetine product. Fluoxe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-03-04FDA Approved: DESVENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for desvenlafaxine succinate from Alembic Pharmaceuticals Limited, enabling the generic product to b…
-
FDA approval · 2019-02-21FDA Approved: ARIPIPRAZOLE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic version of aripiprazole.
-
FDA approval · 2019-02-08FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic fluoxetine hydrochloride under an original application (ANDA).
-
FDA approval · 2019-01-31FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for sertraline hydrochloride from Rising Pharma Holdings, expanding the availability of a generi…
-
FDA approval · 2019-01-28FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original application for bupropion hydrochloride as a generic drug. The approval was issued to Rising Pharma Holdings, Inc.
-
FDA approval · 2019-01-25FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (NorthStar Rx LLC)
FDA approved an original generic application for fluoxetine hydrochloride from NorthStar Rx LLC. Fluoxetine hydrochloride is used to treat m…
-
FDA approval · 2019-01-24FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s generic Bupropion Hydrochloride XL as an extended-release antidepressant under an ANDA supplement…
-
FDA approval · 2019-01-11FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Celexa (citalopram) submitted by Allergan, Inc.
-
FDA approval · 2019-01-10FDA Approved: FLUOXETINE — Original Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals' original abbreviated new drug application for fluoxetine hydrochloride (generic fluoxetine), authorizi…
-
FDA approval · 2018-12-27FDA Approved: TRIMIPRAMINE MALEATE — Supplemental Application (Elite Laboratories, Inc.)
FDA approved a supplemental application for trimipramine maleate from Elite Laboratories, Inc., effectively approving a change to an existin…
-
FDA approval · 2018-11-23FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Marlex Pharmaceuticals, Inc.)
FDA approved a generic venlafaxine hydrochloride product from Marlex Pharmaceuticals, marking the first original ANDA approval for this gene…
-
FDA approval · 2018-11-21FDA Approved: FLUOXETINE HYDROCHLORIDE — Original Application (Taro Pharmaceuticals U.S.A., Inc.)
FDA granted approval for the original application of a generic fluoxetine hydrochloride product.
-
FDA approval · 2018-11-21FDA Approved: VENLAFAXINE — Original Application (Cadila Pharmaceuticals Limited)
FDA approved the original generic application for venlafaxine from Cadila Pharmaceuticals Limited.
-
FDA approval · 2018-11-19FDA Approved: OLANZAPINE — Original Application (HEC Pharm USA Inc.)
The FDA approved the original ANDA application for olanzapine, granting generic status to HEC Pharm USA Inc. for this antipsychotic drug.
-
FDA approval · 2018-11-09FDA Approved: NORPRAMIN — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA has approved a supplemental application for Norpramin (desipramine hydrochloride) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2018-10-31FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for a generic bupropion hydrochloride product. The approval supports use for major dep…
-
FDA approval · 2018-10-19FDA Approved: TRINTELLIX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for vortioxetine (Trintellix) submitted by Takeda Pharmaceuticals America. The approval updates …
-
FDA approval · 2018-10-16FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approves the original generic application for Bupropion Hydrochloride SR, enabling Slate Run Pharmaceuticals to market a generic sustain…
-
FDA approval · 2018-09-28FDA Approved: QUETIAPINE EXTENDED-RELEASE — Original Application (AlignScience Pharma Inc.)
FDA approved AlignScience Pharma Inc.'s generic extended-release quetiapine tablets (ANDA 209497). The approval enables a generic version of…
-
FDA approval · 2018-07-23FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Bupropion from Zydus Pharmaceuticals USA Inc., indicating an approved update to an existing Bupr…